P Romestaing
Overview
Explore the profile of P Romestaing including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
108
Citations
468
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gerard J, Baulieux J, Doyen J, Gal J, Letouze E, Olschwang S, et al.
Cancer Radiother
. 2012 Nov;
16(8):688-96.
PMID: 23153504
Purpose: In 1998 a translational research was initiated in Lyon aiming at identifying a prognostic "biomolecular signature" in rectal cancer. This paper presents the clinical outcome of the patients included...
2.
3.
Remonnay R, Morelle M, Pommier P, Haie-Meder C, Quetin P, Kerr C, et al.
Cancer Radiother
. 2010 Mar;
14(3):161-8.
PMID: 20206571
Purpose: Our study aims at evaluating the cost of pulsed dose-rate (PDR) brachytherapy with optimized dose distribution versus traditional treatments (iridium wires, cesium, non-optimized PDR). Issues surrounding reimbursement were also...
4.
Cutuli B, Le-Nir C, Serin D, Kirova Y, Gaci Z, Lemanski C, et al.
Crit Rev Oncol Hematol
. 2009 May;
73(3):246-54.
PMID: 19442535
Background: Infiltrating MBC represents less than 1% of all male cancers. Our study details clinico-pathological features, treatments and prognostic factors in a large French cohort. Material And Methods: Four hundred...
5.
Letrilliart L, Milliat-Guittard L, Romestaing P, Schott A, Berthoux N, Colin C
Eur J Cancer Care (Engl)
. 2009 Mar;
18(2):131-9.
PMID: 19267728
Before electronic records become operational, patient-held records provide an opportunity to improve communication between patients and healthcare professionals. Our aim was to design the appropriate organization, layout and content for...
6.
Falandry C, Debled M, Bachelot T, Delozier T, Cretin J, Romestaing P, et al.
Breast Cancer Res Treat
. 2008 Nov;
116(3):501-8.
PMID: 19020973
The aim of this study was to evaluate antitumor effects of cyclooxygenase-2 inhibitors in breast carcinoma and their ability to act synergistically with aromatase inhibitors (AIs). Postmenopausal metastatic breast cancer...
7.
Hennequin C, Romestaing P, Maylin C
Cancer Radiother
. 2008 Oct;
12(6-7):559-64.
PMID: 18951822
Postoperative radiotherapy after breast surgery increases overall survival by decreasing the local relapse rate. The main site of relapse is the breast or the chest wall. The value of irradiation...
8.
Azria D, Auvray H, Barillot I, Baumann P, Benyoucef A, Bons-Rosset F, et al.
Cancer Radiother
. 2008 Aug;
12(6-7):571-6.
PMID: 18703372
Ductal carcinoma in situ is defined as breast cancer confined to the ducts of the breast without evidence of penetration of the basement membrane. Local treatment quality represents one of...
9.
Milliat-Guittard L, Romestaing P, Letrilliart L, Berthoux N, Charlois A, Mere P, et al.
Rev Epidemiol Sante Publique
. 2008 Jun;
56 Suppl 3:S239-46.
PMID: 18538965
Background: The conditions of use and access to medical records have become an important source of interest in the last decade. In this context, our main objective was to assess...
10.
Querleu D, Bonnier P, Morice P, Narducci F, Lhomme C, Haie-Meder C, et al.
Gynecol Obstet Fertil
. 2008 May;
36(3):338-52.
PMID: 18494150
No abstract available.